Deroy & Devereaux Private Investment Counsel Inc. trimmed its stake in shares of Morgan Stanley (NYSE:MS - Free Report) by 3.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 302,648 shares of the financial services provider's stock after selling 10,301 shares during the period. Morgan Stanley comprises about 2.6% of Deroy & Devereaux Private Investment Counsel Inc.'s portfolio, making the stock its largest position. Deroy & Devereaux Private Investment Counsel Inc.'s holdings in Morgan Stanley were worth $53,729,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also added to or reduced their stakes in MS. Olistico Wealth LLC acquired a new position in Morgan Stanley in the 4th quarter worth $27,000. Lodestone Wealth Management LLC acquired a new stake in shares of Morgan Stanley in the 4th quarter valued at about $28,000. WFA of San Diego LLC acquired a new stake in shares of Morgan Stanley in the 2nd quarter valued at about $28,000. Greykasell Wealth Strategies Inc. lifted its holdings in shares of Morgan Stanley by 65.2% in the third quarter. Greykasell Wealth Strategies Inc. now owns 185 shares of the financial services provider's stock valued at $29,000 after purchasing an additional 73 shares in the last quarter. Finally, Strive Asset Management LLC bought a new stake in shares of Morgan Stanley in the third quarter valued at about $34,000. 84.19% of the stock is owned by institutional investors.
Morgan Stanley Price Performance
NYSE:MS opened at $188.95 on Friday. The company has a debt-to-equity ratio of 3.39, a quick ratio of 0.81 and a current ratio of 0.81. The stock's 50-day simple moving average is $168.83 and its 200 day simple moving average is $170.76. The company has a market cap of $298.80 billion, a P/E ratio of 17.11, a P/E/G ratio of 1.48 and a beta of 1.19. Morgan Stanley has a 52-week low of $104.78 and a 52-week high of $194.59.
Morgan Stanley (NYSE:MS - Get Free Report) last released its earnings results on Wednesday, April 15th. The financial services provider reported $3.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.02 by $0.41. Morgan Stanley had a return on equity of 17.89% and a net margin of 14.65%.The business had revenue of $20.58 billion for the quarter, compared to analyst estimates of $19.23 billion. During the same quarter in the prior year, the company posted $2.60 earnings per share. Morgan Stanley's revenue was up 16.0% on a year-over-year basis. As a group, sell-side analysts forecast that Morgan Stanley will post 8.56 EPS for the current fiscal year.
Morgan Stanley Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Thursday, April 30th will be paid a dividend of $1.00 per share. The ex-dividend date is Thursday, April 30th. This represents a $4.00 dividend on an annualized basis and a dividend yield of 2.1%. Morgan Stanley's dividend payout ratio is currently 36.23%.
Trending Headlines about Morgan Stanley
Here are the key news stories impacting Morgan Stanley this week:
- Positive Sentiment: Q1 results beat expectations: revenue and EPS surprised on the upside, driven by strong trading and investment‑banking performance and continued wealth‑management flows — the core earnings beat is the primary driver of investor optimism. MS Q1 Deep Dive: Wealth and Investment Banking Deliver
- Positive Sentiment: MSBT (Morgan Stanley’s spot Bitcoin ETF) has drawn >$100M in its first week — a fast start that supports asset‑gathering momentum and fee diversification at the firm. Morgan Stanley Bitcoin ETF Tops $100 Million in Six Days
- Positive Sentiment: Wall Street is increasing MS valuation assumptions: several firms raised price targets and upgraded outlooks after Q1 (Bank of America, Evercore, Argus, Keefe Bruyette & Woods among them), which supports further upside narratives. Morgan Stanley Price Target Raised to $225.00 at Bank of America
- Neutral Sentiment: Dividend and capital return: Morgan Stanley announced a $1.00 quarterly dividend (ex‑dividend Apr 30), signaling confidence in cash generation and returning capital to shareholders (income‑supporting but not an earnings catalyst).
- Neutral Sentiment: Ongoing investment banking / underwriting activity (including large debt syndications) highlights the firm’s franchise utility in markets — positive for fee pipelines but cyclically sensitive to capital‑markets activity.
- Negative Sentiment: Regulatory / reputational overhang: Senator Elizabeth Warren requested Fed records tied to a Fed nominee’s past actions that reference Morgan Stanley; while not an immediate earnings issue, it increases political/regulatory headline risk. Elizabeth Warren Challenges Fed Chair Nominee Kevin Warsh
- Negative Sentiment: Some analysts still express caution: a few firms kept conservative ratings or raised PTs while maintaining neutral/hold views (e.g., HSBC/Rothschild adjustments), which can cap near‑term upside and prompt mixed trading. HSBC Adjusts Price Target on Morgan Stanley
Analyst Ratings Changes
A number of research analysts recently issued reports on MS shares. Wall Street Zen upgraded Morgan Stanley from a "hold" rating to a "buy" rating in a report on Friday, January 23rd. Citizens Jmp restated a "market perform" rating on shares of Morgan Stanley in a research note on Thursday. Wolfe Research reduced their price target on Morgan Stanley from $221.00 to $197.00 and set an "outperform" rating for the company in a research report on Wednesday, April 1st. Evercore raised their price target on shares of Morgan Stanley from $190.00 to $210.00 and gave the stock an "outperform" rating in a research note on Thursday. Finally, Barclays lifted their price objective on shares of Morgan Stanley from $219.00 to $230.00 and gave the company an "overweight" rating in a report on Thursday. Ten research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Morgan Stanley currently has a consensus rating of "Hold" and a consensus price target of $199.67.
Read Our Latest Research Report on MS
Insider Activity at Morgan Stanley
In other news, insider Charles A. Smith sold 8,500 shares of the stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $182.08, for a total value of $1,547,680.00. Following the completion of the sale, the insider owned 119,128 shares of the company's stock, valued at approximately $21,690,826.24. This represents a 6.66% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Michael A. Pizzi sold 20,000 shares of the firm's stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $184.55, for a total transaction of $3,691,000.00. Following the completion of the transaction, the insider directly owned 127,872 shares of the company's stock, valued at $23,598,777.60. This represents a 13.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 195,549 shares of company stock worth $36,260,510. Insiders own 0.17% of the company's stock.
Morgan Stanley Company Profile
(
Free Report)
Morgan Stanley NYSE: MS is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company's chief executive and chairman in recent years.
The firm's primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Morgan Stanley, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morgan Stanley wasn't on the list.
While Morgan Stanley currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of ten stocks that are set to soar in 2026, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.